<DOC>
	<DOCNO>NCT00922714</DOCNO>
	<brief_summary>This prospective double-blinded placebo-controlled block randomize study intensive care patient compare intravenous glutamine supplementation placebo . The hypothesis improvement clinical outcome . The primary endpoint reduction Sequential Organ Failure Assessment ( SOFA ) score day 7 treatment .</brief_summary>
	<brief_title>Scandinavian Intensive Care Unit ( ICU ) Glutamine Study</brief_title>
	<detailed_description>This prospective double-blinded placebo-controlled block randomise study intensive care patient compare intravenous glutamine supplementation ( 0.285 g/kg body weight/24 h ) placebo . Inclusion criteria patient treat 3 day . Primary endpoint reduction SOFA-score day 7 treatment . Secondary endpoint : ICU-mortality , 6-months mortality , length ICU stay , organ failure free day well reduction SOFA-score day 10 treatment . Nutrition standardise less 80 % target basal energy expenditure accord Harris &amp; Benedict give daily . Enteral nutrition prefer , combination enteral parenteral nutrition recommend achieve nutritional target . For statistical comparison non-parametric rank order statistic use . To detect 0.75-point difference reduction SOFA-score day 7 treatment , total 1,000 patient need .</detailed_description>
	<criteria>admission ICU decision give patient full nutrition APACHE II score &gt; 10 admission age 1885 year readmission ICU previous ICUstay patient include study subject condition opinion attend physician make subject unsuitable inclusion inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Glutamine</keyword>
	<keyword>ICU patient</keyword>
	<keyword>Critically ill</keyword>
	<keyword>Nutrition</keyword>
</DOC>